Darbepoetin in Neonatal Encephalopathy Trial
NCT04432662
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
150
Enrollment
OTHER
Sponsor class
Conditions
Neonatal Encephalopathy
Interventions
DRUG:
Darbepoetin Alfa
Sponsor
Imperial College London